Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3060]
News [6210]
Articles [124]
Editorials [18]
Conferences [183]
elearning [32]
Cabozantinib most effective treatment for metastatic papillary kidney cancer
Dr Sumanta Pal - City of Hope, Duarte, USA
Cabozantinib most effective treatment for metastatic papillary kidney cancer ( Dr Sumanta Pal - City of Hope, Duarte, USA )
26 Feb 2021
Sequencing endocrine treatment in metastatic luminal breast cancer and...
Prof Hope Rugo - University of California San Francisco, San Francisco, USA
Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC ( Prof Hope Rugo - University of California San Francisco, San Francisco, USA )
24 Feb 2021
Long term response to apalutamide and other updates impacting patients with...
Prof Axel Merseburger and Prof Matthew Smith
Long term response to apalutamide and other updates impacting patients with nmCRPC from ASCO GU 2021 ( Prof Axel Merseburger and Prof Matthew Smith )
22 Feb 2021
mCRPC and nmCRPC: Combinations and latest data, what does COVID mean for early...
Dr Eleni Efstathiou, Prof Stefan Oudard Prof Boris Hadaschik and Prof Gerhardt...
mCRPC and nmCRPC: Combinations and latest data, what does COVID mean for early treatment? ( Dr Eleni Efstathiou, Prof Stefan Oudard Prof Boris Hadaschik and Prof Gerhardt Attard )
19 Feb 2021
Diagnosis, testing and biomarkers in the individualisation of patient care with...
Prof Andrea Necchi and Prof Eva Compérat
Diagnosis, testing and biomarkers in the individualisation of patient care with FGFR mutated bladder cancer ( Prof Andrea Necchi and Prof Eva Compérat )
18 Feb 2021
Nurse's perspective on PARP inhibitors and personalised medicine in prostate...
Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK
Nurse's perspective on PARP inhibitors and personalised medicine in prostate cancer ( Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK )
17 Feb 2021
ITACA NSCLC study: Final results
Prof Silvia Novello - University of Turin, Turin, Italy
ITACA NSCLC study: Final results ( Prof Silvia Novello - University of Turin, Turin, Italy )
16 Feb 2021
KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with...
Prof Michael Boyer - Chris O’Brien Lifehouse, Sydney, Australia
KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic NSCLC ( Prof Michael Boyer - Chris O’Brien Lifehouse, Sydney, Australia )
16 Feb 2021
TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair...
Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France
TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair alterations and mCRPC ( Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France )
15 Feb 2021
ASCO GU 2021: Renal cancer roundup
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ASCO GU 2021: Renal cancer roundup ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
15 Feb 2021
TITAN: Update and where next for patients with hormone sensitive PC
Prof Axel Merseburger and Prof Kim Chi
TITAN: Update and where next for patients with hormone sensitive PC ( Prof Axel Merseburger and Prof Kim Chi )
15 Feb 2021
OncoAlert and ecancer weekly roundup for February 07 - 13, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for February 07 - 13, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
15 Feb 2021

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation